论文部分内容阅读
目的:探讨痰热清联合头孢呋辛钠治疗肺气肿感染的治疗效果。方法:以2013年8月~2014年8月医院收治的肺气肿感染患者80例为实验组,给予痰热清联合头孢呋辛钠治疗,随机选择同期医院收治的肺气肿感染患者78例作为对照组,给予头孢呋辛钠治疗,治疗3周后,比较两组患者的治疗效果及临床指标恢复时间。结果:经过3周治疗之后,实验组患者的治疗总有效率高于对照组患者,且临床指标恢复时间低于对照组,比较差异具有统计学意义(P<0.05)。结论:治疗肺气肿感染时,痰热清联合头孢呋辛钠的治疗效果优于头孢呋辛钠单一治疗效果,应在临床中推广应用。
Objective: To investigate the therapeutic effect of Tanreqing combined with cefuroxime sodium in the treatment of emphysema infection. Methods: From August 2013 to August 2014, 80 patients with emphysema admitted to the hospital were selected as the experimental group. Tanreqing and cefuroxime sodium were given to the experimental group. 78 patients with emphysema were randomly selected in the same hospital. As a control group, cefuroxime sodium was given. After 3 weeks of treatment, the therapeutic effect and the recovery time of clinical indexes of the two groups were compared. Results: After 3 weeks of treatment, the total effective rate of treatment group was higher than that of control group, and the recovery time of clinical index was lower than that of control group. The difference was statistically significant (P <0.05). Conclusion: The treatment of patients with emphysema, Tanreqing combined with cefuroxime sodium is superior to the single-treatment effect of cefuroxime sodium, should be widely used in clinical practice.